E
180 Life Sciences Corp. ATNF
$0.8985 $0.02132.43% NASDAQ
Recommendation
Prev Close
$0.8985
Volume
20,872
Avg Vol (90D)
328,539
Market Cap
$4.66M
Dividend & Yield
--
52-Week Range
$0.6578 - $17.75
P/E (TTM)
--
EPS (TTM)
-$13.47
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Weiss Ratings Reiterates "Sell (E+)" Rating for 180 Life Sciences (NASDAQ:ATNF)
2/21/2025 - Ticker Report
Anson Funds Management LP Acquires Shares in 180 Life Sciences Corp
2/15/2025 - GuruFocus
180 Life Sciences Appoints New CEO Amid Leadership Changes
2/7/2025 - TipRanks Financial Blog
180 Life Sciences (NASDAQ:ATNF) Earns "Sell (E+)" Rating from Weiss Ratings
2/4/2025 - Ticker Report
Weiss Ratings Reaffirms Sell (E+) Rating for 180 Life Sciences (NASDAQ:ATNF)
1/20/2025 - Ticker Report
180 Life Sciences Announces Key Proposals and Director Elections
12/31/2024 - TipRanks Financial Blog
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Up 148.1% in December
12/29/2024 - Ticker Report
180 Life Sciences Corp. Announces Pricing of $2. ...
12/27/2024 - GuruFocus
180 Life Sciences announces pricing of $2.9M registered direct offering
12/27/2024 - SeekingAlpha.com: All News
180 Life Sciences announces pricing of $2.9M registered direct offering
12/27/2024 - Seeking Alpha - Healthcare
180 Life Sciences prices $2.9M registered direct offering at $2.41 per share
12/27/2024 - TipRanks Financial Blog
180 Life Sciences prices $2.9M registered direct offering at $2.41 per share
12/27/2024 - The Fly
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
12/27/2024 - Accesswire
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
12/12/2024 - GuruFocus
180 Life Sciences regains compliance with Nasdaq listing rule
12/12/2024 - TipRanks Financial Blog
180 Life Sciences regains compliance with Nasdaq listing rule
12/12/2024 - The Fly
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
12/12/2024 - Accesswire
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
12/4/2024 - GuruFocus
180 Life Sciences appoints Stephen Shoemaker to board of directors
12/4/2024 - TipRanks Financial Blog
180 Life Sciences appoints Stephen Shoemaker to board of directors
12/4/2024 - The Fly
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
12/4/2024 - Accesswire
Short Interest in 180 Life Sciences Corp. (NASDAQ:ATNF) Decreases By 34.9%
11/29/2024 - Ticker Report
180 Life Sciences files to sell 1.9M shares of common stock for holders
11/15/2024 - The Fly
ARMISTICE CAPITAL, LLC Acquires New Stake in 180 Life Sciences Corp
11/15/2024 - GuruFocus
180 Life Sciences Corp. (NASDAQ:ATNF) Short Interest Update
11/14/2024 - Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$6.25M
EBIT (TTM)
-$6.32M
Net Income (TTM)
-$6.17M
Balance Sheet
Total Assets (Q)
$12.76M
Total Debt (Q)
$154.50K
Total Liabilities (Q)
$3.51M
Book Value Per Share (Q)
$2.91
Cash Flow
Cash from Operations (TTM)
-$1.48M
Cash from Investing (TTM)
--
Cash from Financing (TTM)
$4.04M
Net Change in Cash (TTM)
$2.61M
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
2.40
7-Day Total Return
19.58%
30-Day Total Return
-23.86%
60-Day Total Return
-41.27%
90-Day Total Return
-57.01%
Year to Date Total Return
-47.76%
1-Year Total Return
-50.90%
2-Year Total Return
-96.33%
3-Year Total Return
-99.87%
5-Year Total Return
-99.98%
52-week Low
Apr 09, 2025 - $0.6578
52-week High
Oct 16, 2024 - $17.75
Valuation
Market Cap
$4.66M - Nano Cap
Enterprise Value
$228.89K
Price/Sales (TTM)
--
Price/Book (Q)
0.31
Dividends and Shares
Shares Outstanding
1.12M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
180lifesciences.com
Phone Number
650 507 0669
Address
Building 4
Suite 200 - 3000 El Camino Real
Palo Alto, CA 94306
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory... more
NASDAQ 04/17/2025 3:55PM Eastern Quotes delayed